Sandy Draper
Stock Analyst at Guggenheim
(2.94)
# 1,284
Out of 4,829 analysts
119
Total ratings
58.33%
Success rate
19.74%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $313.74 | +37.69% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $156.13 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $143.08 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $9.31 | +265.20% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.35 | +129.89% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $61.04 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.55 | -21.57% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $140.22 | +87.56% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $2.97 | +910.10% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $96.66 | -2.75% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.35 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $25.06 | +103.51% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $157.29 | -17.99% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $30.76 | +78.80% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $53.40 | +214.61% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $55.21 | -78.26% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $23.01 | +65.15% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.10 | +880.39% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $8.51 | +663.81% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $4.52 | +696.46% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $241.44 | -30.83% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.52 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $16.61 | +279.29% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $313.74
Upside: +37.69%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $156.13
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $143.08
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $9.31
Upside: +265.20%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.35
Upside: +129.89%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $61.04
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.55
Upside: -21.57%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $140.22
Upside: +87.56%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $2.97
Upside: +910.10%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $96.66
Upside: -2.75%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.35
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $25.06
Upside: +103.51%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $157.29
Upside: -17.99%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $30.76
Upside: +78.80%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $53.40
Upside: +214.61%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $55.21
Upside: -78.26%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $23.01
Upside: +65.15%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.10
Upside: +880.39%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $8.51
Upside: +663.81%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $4.52
Upside: +696.46%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $241.44
Upside: -30.83%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.52
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $16.61
Upside: +279.29%